EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Whole-exome sequencing association study reveals genetic effects on tumor microenvironment components in nasopharyngeal carcinoma

Yanni Zeng, Chun-Ling Luo, Guo-Wang Lin, Fugui Li, Xiaomeng Bai, Josephine Mun-Yee Ko, Lei Xiong, Yang Liu, Shuai He, Jia-Xin Jiang, Wen-Xin Yan, Enya Hui Wen Ong und 27 weitere

Journal of Clinical Investigation · 2025

DOI: 10.1172/jci182768 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Yanni Zeng und 38 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Cli…. Hauptthemen laut MEDLINE: Tumor Microenvironment, Nasopharyngeal Neoplasms, Nasopharyngeal Carcinoma, Exome Sequencing. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization, National Natural Science Foundation of China, the Sci-Tech Project Foundation of Guangzhou City.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nasopharyngeal carcinoma (NPC) presents a substantial clinical challenge due to the limited understanding of its genetic underpinnings. Here we conduct the largest scale whole-exome sequencing association study of NPC to date, encompassing 6,969 NPC cases and 7,100 controls. We unveil 3 germline genetic variants linked to NPC susceptibility: a common rs2276868 in RPL14 , a rare rs5361 in SELE , and a common rs1050462 in HLA-B . We also underscore the critical impact of rare genetic variants on NPC heritability and introduce a refined composite polygenic risk score (rcPRS), which outperforms existing models in predicting NPC risk. Importantly, we reveal that the polygenic risk for NPC is mediated by EBV infection status. Utilizing a comprehensive multiomics approach that integrates both bulk-transcriptomic ( n = 356) and single-cell RNA sequencing ( n = 56) data with experimental validations, we demonstrate that the RPL14 variant modulates the EBV life cycle and NPC pathogenesis. Furthermore, our data indicate that the SELE variant contributes to modifying endothelial cell function, thereby facilitating NPC progression. Collectively, our study provides crucial insights into the intricate genetic architecture of NPC, spotlighting the vital interplay between genetic variations and tumor microenvironment components, including EBV and endothelial cells, in predisposing to NPC. This study opens new avenues for advancements in personalized risk assessments, early diagnosis, and targeted therapies for NPC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentNasopharyngeal NeoplasmsNasopharyngeal CarcinomaExome SequencingRibosomal ProteinsHumansMaleFemaleEpstein-Barr Virus InfectionsGenetic Predisposition to DiseaseHerpesvirus 4, HumanNeoplasm ProteinsPolymorphism, Single Nucleotide

Stichwörter der Autor:innen

CancerGenetic variationGeneticsOncology

Substanzen

Ribosomal ProteinsNeoplasm Proteins

Autor:innen und Institutionen

  • State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center…
  • Faculty of Forensic Medicine, Guangdong Province Translational Forensic Medicine Engineering Technology Research Center, and.
  • Guangdong Province Key Laboratory of Brain Function and Disease, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
  • Department of Experimental Research, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Department of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
  • Cancer Research Institute of Zhongshan City, Zhongshan City People's Hospital, Zhongshan, China.

Förderung

  • World Health Organization
  • National Natural Science Foundation of China
  • the Sci-Tech Project Foundation of Guangzhou City
  • the Guangdong Innovative and Entrepreneurial Research Team Program
  • Hong Kong Research Grant Council (RGC) Theme-based Research Scheme Funds
  • National Medical Research Council Singapore Clinician Scientist Award
  • the Research Grants Council Area of Excellence (AoE) Hong Kong NPC Research

Zitieren

APA

Zeng, Y., Luo, C. L., Lin, G. W., Li, F., Bai, X., Ko, J. M., Xiong, L., Liu, Y., He, S., Jiang, J. X., Yan, W. X., Ong, E. H. W., Li, Z., Zhou, Y. Q., Zhou, Y. H., Xu, A. Y., Liu, S. Q., Guo, Y. M., Chen, J. R., …, & Bei, J. X. (2025). Whole-exome sequencing association study reveals genetic effects on tumor microenvironment components in nasopharyngeal carcinoma. Journal of Clinical Investigation. https://doi.org/10.1172/jci182768

Vancouver

Zeng Y, Luo CL, Lin GW, Li F, Bai X, Ko JM, et al. Whole-exome sequencing association study reveals genetic effects on tumor microenvironment components in nasopharyngeal carcinoma. Journal of Clinical Investigation. 2025. doi:10.1172/jci182768

BibTeX
@article{Zeng2025,
  author = {Zeng, Yanni and Luo, Chun-Ling and Lin, Guo-Wang and Li, Fugui and Bai, Xiaomeng and Ko, Josephine Mun-Yee and Xiong, Lei and Liu, Yang and He, Shuai and Jiang, Jia-Xin and Yan, Wen-Xin and Ong, Enya Hui Wen and Li, Zheng and Zhou, Ya-Qing and Zhou, Yun-He and Xu, An-Yi and Liu, Shu-Qiang and Guo, Yun-Miao and Chen, Jie-Rong and Cheng, Xi-Xi and Cao, Yu-Lu and Yu, Xia and Wu, Biaohua and Wei, Pan-Pan and Ruan, Zhao-Hui and Chen, Qiu-Yan and Tang, Lin-Quan and McKay, James D and Jia, Wei-Hua and Mai, Hai-Qiang and Lim, Soon Thye and Liu, Jian-Jun and Lin, Dong-Xin and Khor, Chiea Chuen and Chua, Melvin Lee Kiang and Ji, Mingfang and Lung, Maria Li and Zeng, Yi-Xin and Bei, Jin-Xin},
  title = {Whole-exome sequencing association study reveals genetic effects on tumor microenvironment components in nasopharyngeal carcinoma},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  doi = {10.1172/jci182768}
}
Kostenlos starten →